Parth Desai

Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress

Anish Thomas, Nobuyuki Takahashi, Vinodh N. Rajapakse et al. · Cancer Cell · 2021 · 177 citations · Full text

Medicine, Molecular Biology, Oncology +14

Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes

Lőrinc Sándor Pongor, Christopher W. Schultz, Lorenzo Rinaldi et al. · Cancer Discovery · 2023 · 116 citations · Full text

Medicine, Genetics, Oncology +17

Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models

Delphine Lissa, Nobuyuki Takahashi, Parth Desai et al. · Nature Communications · 2022 · 111 citations · Full text

Medicine, Molecular Biology, Oncology +17

<i><scp>MYC</scp>/<scp>BCL</scp>6</i> double‐hit lymphoma (<scp>DHL</scp>): a tumour associated with an aggressive clinical course and poor prognosis

Shaoying Li, Parth Desai, Pei Lin et al. · Histopathology · 2015 · 106 citations

Medicine, Oncology, Pathology +15

Autophagy inhibition by targeting PIKfyve potentiates response to immune checkpoint blockade in prostate cancer

Yuanyuan Qiao, Jae Eun Choi, Jean C. Tien et al. · Nature Cancer · 2021 · 104 citations · Full text

Life Sciences, Cancer Biology, Oncology +16